Viewing Study NCT00998166


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2026-01-28 @ 2:24 AM
Study NCT ID: NCT00998166
Status: TERMINATED
Last Update Posted: 2024-07-30
First Post: 2009-10-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy
Sponsor: Columbia University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: AAAB9652
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators